We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Multiple Myeloma Patients

News List

NICE approves new tolerable drug carflizomib for multiple myeloma patients on NHS pharmaceutical-technology
July 25, 2017
UK’s National Institute for Health and Care Excellence (NICE) has approved Amgen’s new anti-cancer treatment carflizomib for multiple myeloma patients on the National Health Service (NHS).
FDA Accepts Amgen's Supplemental Biologics License Application to Expand Indication for Xgeva to Inc americanpharmaceuticalreview
June 22, 2017
Amgen announced the U.S. Food and Drug Administration (FDA) has accepted the Xgeva (denosumab) supplemental Biologics License Application (sBLA) that seeks to expand the currently approved indication for the prevention of fractures and other skeletal-rela